{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T23:58:24Z","timestamp":1704326304326},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,11,1]]},"DOI":"10.2169\/internalmedicine.7413-21","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T22:08:37Z","timestamp":1621634917000},"page":"3349-3350","source":"Crossref","is-referenced-by-count":1,"title":["Pheochromocytoma and Paraganglioma: Challenges and Opportunities in 2021"],"prefix":"10.2169","volume":"60","author":[{"given":"Katsutoshi","family":"Takahashi","sequence":"first","affiliation":[{"name":"Division of Metabolism, Showa General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Tischler AS, Papathomas TG, de Krijger RR, et al. Phaeochromocytoma. In: WHO Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. 4th ed. Lloyd RV, Osamura RY, Kloppel G, et al., Eds. IARC Lyon, 2017: 183-189."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Riester A, Weismann D, Quinkler M, et al. Life-threatening events in patients with pheochromocytoma. Eur J Endocrinol 173: 757-364, 2015.","DOI":"10.1530\/EJE-15-0483"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Funazaki S, Yamada H, Hara K. Pseudo intestinal obstruction caused by malignant paraganglioma. Intern Med 60: 3507-3508, 2021.","DOI":"10.2169\/internalmedicine.6801-20"},{"key":"4","unstructured":"4. Japan Endocrine Society clinical guideline committee on malignant pheochromocytoma. [Pheochromocytoma\/Paraganglioma Clinical Practice Guidelines 2018]. Nihon Naibunpitsu Gakkai Zasshi 94 (Suppl): 56-57, 2018 (in Japanese)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Thosani S, Ayala-Ramirez M, Rom\u00e1n-Gonz\u00e1lez A, et al. Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma. Eur J Endocrinol 173: 377-387, 2015.","DOI":"10.1530\/EJE-15-0456"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Groeben H, Nottebaum BJ, Alesina PF, et al. Perioperative \u03b1-receptor blockade in phaeochromocytoma surgery: an observational case series. Br J Anaesth 118: 182-189, 2017.","DOI":"10.1093\/bja\/aew392"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lam AK. Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours. Endocr Pathol 28: 213-227, 2017.","DOI":"10.1007\/s12022-017-9484-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Neumann HPH, Young WF Jr, Eng C. Pheochromocytoma and Paraganglioma. N Engl J Med 381: 552-565, 2019.","DOI":"10.1056\/NEJMra1806651"},{"key":"9","unstructured":"9. Takekoshi K. [Pheochromocytoma and paraganglioma: recent topics]. Naika (Intern Med) 124: 2469-2475, 2019 (in Japanese)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kalia SS, Adelman K, Bale SJ, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 19: 249-255, 2017.","DOI":"10.1038\/gim.2016.190"},{"key":"11","unstructured":"11. Patient Disclosure Recommendation List of Secondary Findings of Oncogene Panel Testing [Internet]. [cited 2021 Feb 1]. Available from: https:\/\/www.amed.go.jp\/news\/seika\/kenkyu\/20200121.html"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/21\/60_7413-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T03:20:52Z","timestamp":1636168852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/21\/60_7413-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":11,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7413-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"article-number":"7413-21"}}